GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of three years of mechanism threads, summarised so you do not have to read them — 49 comments in the full submission. View in context.
2k
c/glp1science·submitted 3 months ago by u/bastian_eriksen

three years of mechanism threads, summarised so you do not have to read them

Discussionbranch of 11 comments

Quick one. Canada here. mechanism works very differently where I live than in the threads that dominate the front page, and I keep seeing people confidently given advice that simply does not apply outside the US. Specifics: the route I used took 13 weeks and cost roughly what I expected. The admin was worse than the…

Read the full submission and all 49 comments →

This branch

11 comments, started 3 months ago
u/hassan_castellanos-8 points·3 months ago

Sceptical. If this were true we would see it reflected in the data and we do not.

replysharereportpermalink
u/second_week_sceptic1 point·3 months ago

glucagon-receptor contribution is pharmacology for dual and triple agonism

replysharereportpermalink
u/bastian_ekstrom1 point·3 months ago

The confident tone is doing a lot of work that the evidence is not.

replysharereportpermalink
u/kian_balogun1 point·3 months ago·edited

Yeah, the incretin mechanism is doing the work here.

replysharereportpermalink
u/employer_carveout1 point·3 months ago

Disagree. What you are describing is consistent with half-life, not with what you concluded.

replysharereportpermalink
u/bastian_eriksenOP1 point·3 months ago

Disagree but this is the good kind of wrong — it is specific enough to be checked.

replysharereportpermalink
u/bastian_eriksenOP1 point·3 months ago

Stomach physiology changed when I moved up to 1.7mg. Gastric emptying lag is the whole story.

replysharereportpermalink
load more comments (4) →

← back to the whole thread

About c/glp1science

The mechanism layer: incretin physiology, receptor distribution, gastric emptying, central appetite signalling, glucagon-receptor contribution, amylin co-agonism, and the pharmacokinetics that make weekly dosing possible. Papers get cited by journal and year or they get a [needs source] reply.

50kmembers
95submissions
Oct 2023created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/glp1science rules
  1. Cite the paper: journal, year, first author. Links optional, citation mandatory.
  2. Mechanistic speculation is welcome if flaired as speculation.
  3. No extrapolating rodent data to human dosing without saying that is what you are doing.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.